Get the Stockscreener App
11.84
1.82%
-0.22
After Hours:
11.95
0.11
+0.93%
Phathom Pharmaceuticals Inc stock is traded at $11.84, with a volume of 775.50K.
It is down -1.82% in the last 24 hours and up +14.07% over the past month.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
See More
Previous Close:
$12.06
Open:
$12.19
24h Volume:
775.50K
Relative Volume:
0.58
Market Cap:
$839.97M
Revenue:
$114.04M
Net Income/Loss:
$-330.15M
P/E Ratio:
-2.5032
EPS:
-4.73
Net Cash Flow:
$-274.85M
1W Performance:
-4.05%
1M Performance:
+14.07%
6M Performance:
+136.80%
1Y Performance:
-39.28%
1-Day Range:
$11.51
$12.20
1-Week Range:
$11.51
$13.00
52-Week Range:
$2.21
$19.71
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
Name
Phathom Pharmaceuticals Inc
Sector
Industry
Phone
(877) 742-8466
Address
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Compare PHAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHAT
Phathom Pharmaceuticals Inc
|
11.84 | 874.03M | 114.04M | -330.15M | -274.85M | -4.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-24 | Initiated | Stifel | Buy |
| Jan-05-24 | Reiterated | Needham | Buy |
| Aug-09-23 | Initiated | H.C. Wainwright | Buy |
| May-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-13-23 | Initiated | Craig Hallum | Buy |
| Oct-21-22 | Initiated | Jefferies | Buy |
| May-06-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-12-21 | Upgrade | Goldman | Sell → Neutral |
| Feb-17-21 | Initiated | BMO Capital Markets | Outperform |
| Feb-02-21 | Initiated | Guggenheim | Buy |
| Jun-26-20 | Downgrade | Goldman | Neutral → Sell |
| Nov-20-19 | Initiated | Evercore ISI | Outperform |
| Nov-19-19 | Initiated | Goldman | Neutral |
| Nov-19-19 | Initiated | Jefferies | Buy |
| Nov-19-19 | Initiated | Needham | Buy |
View All
Phathom Pharmaceuticals Inc Stock (PHAT) Latest News
596,108 Shares in Phathom Pharmaceuticals, Inc. $PHAT Bought by Jacobs Levy Equity Management Inc. - MarketBeat
Phathom Pharmaceuticals officer sells $5573 in stock By Investing.com - Investing.com Canada
Phathom Pharmaceuticals officer sells $5573 in stock - Investing.com
101,520 Shares in Phathom Pharmaceuticals, Inc. $PHAT Purchased by Nuveen LLC - MarketBeat
Wall Street Analysts See a 66.13% Upside in Phathom Pharmaceuticals (PHAT): Can the Stock Really Move This High? - Yahoo Finance
Recovery Signals Appearing in Phathom Pharmaceuticals Inc. Charts2025 EndofYear Setup & Weekly High Return Stock Opportunities - beatles.ru
Phathom Pharmaceuticals: The IP Question Is Answered, But Can Management Deliver (Rating Upgrade) - Seeking Alpha
683 Capital Management LLC Has $9.06 Million Position in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Chart based analysis of Phathom Pharmaceuticals Inc. trendsOil Prices & Capital Protection Trade Alerts - Newser
Is Phathom Pharmaceuticals Inc. stock overvalued or fairly pricedGDP Growth & Expert Verified Stock Movement Alerts - خودرو بانک
Can Phathom Pharmaceuticals Inc. weather a recessionRecession Risk & Reliable Intraday Trade Alerts - خودرو بانک
Signal strength of Phathom Pharmaceuticals Inc. stock in tech scanners2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Russell Investments Group Ltd. Invests $262,000 in Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Visual analytics tools that track Phathom Pharmaceuticals Inc. performanceCEO Change & Consistent Growth Equity Picks - Newser
What the charts say about Phathom Pharmaceuticals Inc. todayWeekly Risk Summary & AI Enhanced Trading Signals - Newser
Phathom Pharmaceuticals, Inc. $PHAT Holdings Lifted by Propel Bio Management LLC - MarketBeat
What recovery options are there for Phathom Pharmaceuticals Inc.2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
How to forecast Phathom Pharmaceuticals Inc. trends using time series2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Institutional scanner results for Phathom Pharmaceuticals Inc.Earnings Performance Report & AI Driven Stock Movement Reports - Newser
Is Phathom Pharmaceuticals Inc. building a consolidation base2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Has Phathom Pharmaceuticals Inc. formed a bullish divergenceMarket Performance Summary & Capital Protection Trade Alerts - Newser
How hedge fund analytics apply to Phathom Pharmaceuticals Inc. stock2025 Key Lessons & Daily Volume Surge Trade Alerts - Newser
Detecting support and resistance levels for Phathom Pharmaceuticals Inc.Trade Volume Summary & Growth Focused Entry Point Reports - Newser
What’s next for Phathom Pharmaceuticals Inc. stock priceWeekly Investment Recap & AI Based Buy and Sell Signals - Newser
Will Phathom Pharmaceuticals Inc. stock recover after earningsStock Surge & Accurate Intraday Trading Signals - خودرو بانک
Is Phathom Pharmaceuticals Inc. a turnaround storyWeekly Trade Analysis & Verified Short-Term Trading Plans - خودرو بانک
Is Phathom Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Drop Watch & Risk Managed Investment Signals - خودرو بانک
Momentum divergence signals in Phathom Pharmaceuticals Inc. chartWeekly Profit Recap & Precise Swing Trade Entry Alerts - Newser
Dividend Watch: Is Phathom Pharmaceuticals Inc. a top pick in the sector2025 Risk Factors & Verified Short-Term Trading Plans - خودرو بانک
Advanced analytics toolkit walkthrough for Phathom Pharmaceuticals Inc.Earnings Summary Report & Daily Momentum Trading Reports - Newser
Is Phathom Pharmaceuticals Inc. still worth holding after the dipWeekly Trade Report & Community Verified Trade Alerts - Newser
How to read the order book for Phathom Pharmaceuticals Inc.Portfolio Risk Summary & Fast Moving Trade Plans - Newser
Combining machine learning predictions for Phathom Pharmaceuticals Inc.Wall Street Watch & Real-Time Chart Breakout Alerts - Newser
Why Phathom Pharmaceuticals Inc. is moving todayPortfolio Update Report & Risk Adjusted Swing Trade Ideas - Newser
Institution Moves: Will Phathom Pharmaceuticals Inc. benefit from rate cuts2025 Valuation Update & Safe Capital Growth Plans - خودرو بانک
Using data filters to optimize entry into Phathom Pharmaceuticals Inc.Volume Spike & Pattern Based Trade Signal System - Newser
Is Phathom Pharmaceuticals Inc. a top pick in the sectorMarket Activity Report & High Accuracy Swing Entry Alerts - خودرو بانک
How moving averages guide Phathom Pharmaceuticals Inc. tradingEarnings Trend Report & Verified Technical Trade Signals - Newser
Published on: 2025-08-31 22:05:23 - Newser
Backtesting results for Phathom Pharmaceuticals Inc. trading strategiesPortfolio Value Report & Accurate Trade Setup Notifications - Newser
Will a bounce in Phathom Pharmaceuticals Inc. offer an exitJuly 2025 Fed Impact & Verified Swing Trading Watchlist - Newser
Can a trend reversal in Phathom Pharmaceuticals Inc. lead to recoveryEarnings Growth Summary & Stepwise Swing Trade Plans - Newser
Phathom Pharmaceuticals Inc. stock retracement – recovery analysis2025 Retail Activity & Real-Time Price Movement Reports - Newser
Is Phathom Pharmaceuticals Inc. the Top Chart Pick This Week getLinesFromResByArray error: size == 0 - thegnnews.com
Phathom Pharmaceuticals Inc Stock (PHAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):